AVNSAvanos Medical, Inc.

$24.99

Is it safe?

Can AVNS take a bad year?

The deepest fall in AVNS's price history on file is −86%; it is 0.24% below its high today.

$22M

Net debt · as at Q1 2026 · debt less the cash on hand, with no positive EBITDA to service it

Altman Z-score
2.03

Altman Z-score · grey zone, between 1.8 and 3

Interest cover
none

Interest cover · no operating profit to pay the interest bill from

Annualised volatility
61%

Annualised volatility · three times the market's own swing

Details
Total debtQ1 2026
$87M
Cash and short-term investments
$66M
Net debt
$22M
EBITDA, trailing twelve months
−$33M
Operating profit, trailing twelve months
−$63M
Debt / equity
0.11×
Annualised volatilitytwo years of daily moves
61%
Worst drawdown on file
−86%
Below its 52-week high
0.24%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.